CSIMarket
 
Cintas Corporation  (CTAS)
Other Ticker:  
 
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services
 



EARNINGS REPORT by CSIMarket

Double Digit EPS Growth, Sales Lower

Cintas Corporation announced second quarter 2020 operating profit of $352.872 millions, company sees it's eps at $ 3.84

Despite soft demand in the second quarter 2020, company managed to increase it's earnings per share, income increased by 15.42 % to $2.62 per share while Sales fell by -4.7 % to $1.76 billions, year on year.
The_U.S._Army_pd
Looking into results from previous quarter Sales increased by 0.6 % from $1.75 billions and eps decreased by -5.76 % from $2.78 per share.
Sales fell at Uniform Direct Sales -5.38%, while revenue growth was achieved at Rental Uniforms or Ancillary Products +9.52%, First Aid, Safety or Fire Protection +14.95%.
Rental Uniforms or Ancillary Products segment with 15.91% is solely responsible for the income gain, Cintas Corporation continued, while company logged declining profits in Uniform Direct Sales -6.48%, First Aid, Safety or Fire Protection -0.74%. Earnings grew 15.74 % to $284.857 millions for the second quarter 2020, compare to income of $246.120 millions achieved a year before. Cintas Corporation also emphasized it's improving profit margins, where net margin rose to 16.21% in second quarter 2020, and operating margin edged up to 20.08%. Company increased it's earnings and sales estimates, earnings per share by $0.05 to the new range between $3.79 and $ 3.88, while company now see it's revenues between $4,800 millions and $4,880 millions for the fiscal Year, higher by $0.05 millions from previous guidance.


Cintas Corporation is expected to report next financial results on March 24, 2021.


    Recently Reported Results
Dryvax_pd Rasna Therapeutics Inc

Company reports $-2.29 million loss, as impairment charges strip off $2.27 million from the fiscal period ending Sep 30 2020 results., company sees it's eps at $ 3.84

Company reports $-2.29 million loss, as impairment charges strip off $2.27 million from the fiscal period ending Sep 30 2020 results.

Rasna Therapeutics Inc reported operating deficit of $-5.005433 millions, in the fiscal period ending Sep 30 2020, a deterioration from the operating loss of $-0.060707 millions, realized in fourth quarter of 2019

RASP stock quotes, charts, profile

Growth Rates, Profitability, PE

TPIRWordmark Producer Price Index

Wholesale prices climbed 0.1 % in November

U.S. Wholesale prices rose 0.1 % in November, led by growth in food, materials for manufacturing and crude petroleum prices.

161026-G-MI999-007o__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Volt Information Sciences Inc

Volt Information Sciences Inc announced financial time frame ending Nov 01 2020 operating loss of $-11.462 millions

In the financial time frame ending Nov 01 2020 Volt Information Sciences Inc increased losses of $-0.58 per share compared to $-0.04 a year ago and increased losses from $-0.22 per share from the previous quarter.

Sales declined in double digits by -18.32% to $211.07 millions from $258.41 millions in the same quarter a year ago and sequentially Sales advanced by 13.52 % from $185.94 millions.

VOLT stock quotes, charts, profile

Growth Rates, Profitability, PE

Model2100sm_By_Goldstein_Group__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Aehr Test Systems

Deficit Widen, Topline Tumbles

Aehr Test Systems reported disastrous financial second quarter of 2020, where Sales faded by -75.52% to $1.68 millions and loss per share has widen at $-0.08, from the same quarter a year ago.

remained unchanged from the preceding quarter from $0.00 per share, Sales fell by -16.35% from $2.01 millions.

AEHR stock quotes, charts, profile

Growth Rates, Profitability, PE

drilling_engineering_lathe_manufacturing_machine_metal_industrial_machining-771478 Greystone Logistics Inc

Greystone Logistics Inc announced most recent fiscal period operating profit of $1.769026 millions

Company reported strong income growth of 200 % to $0.03 per share, on fading Sales of -20.41% to $15.52 millions in the most recent fiscal period, compared to previous year.

In contrast to the first quarter Sales deteriorated by -11.64% from $17.57 millions and eps remained unchanged from $0.03 per share.

GLGI stock quotes, charts, profile

Growth Rates, Profitability, PE

house-1525913_960_720 Housing Starts

Construction of new homes in U.S. continue to grow

Housing starts continue to increase after recent decline, as construction of multi-family housing units as well as growing demand for single-family homes, helped to clinch a 1.1 % gain in November.

Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

New Orders 1.41 % in November

Durable Goods orders continued to grow, as bookings outgrow production.

Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

New Orders up 1.34 % in November

Factory orders continued to grow, as bookings outgrow production.

29186943363_88cb6b059f_z Daybreak Oil and Gas Inc

Break-even, Topline Crumbles

Daybreak Oil And Gas Inc recorded operating deficit of $-0.095615 millions, in the third quarter of 2020, a degradation from the operating loss of $-0.072688 millions, reported in third quarter of 2019

Sales faded by -32.15% to $0.10 millions from $0.14 millions in the same quarter a year ago and sequentially Sales deteriorated by -11.28% from $0.11 millions.

DBRM stock quotes, charts, profile

Growth Rates, Profitability, PE

8435305475_740c95084f_z Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc announced financial first quarter of 2020 operating surplus of $5.827 millions

In the financial first quarter of 2020 Oramed Pharmaceuticals Inc earnings jumped by 53.33 % of $0.23 per share compared to $0.15 a year ago and eps soared by 81.35 % from $0.13 per share from the previous quarter.

Sales remained unchanged by 0% to $0.67 millions from $0.67 millions in the same quarter a year ago and sequentially Sales decreased by -1.03% from $0.68 millions.

ORMP stock quotes, charts, profile

Growth Rates, Profitability, PE

Mikroprozessor_By_Elmar_Ersch_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Semileds Corp

Losses Widen, Topline Tumbles

Semileds Corp reported disastrous fiscal first quarter of 2020, where Sales faded by -54% to $0.72 millions and loss per share has widen to $-0.17, from the same quarter a year ago.

Eps soared from the preceding quarter from $-0.01 per share, Sales Tumbled by -48.61% from $1.40 millions.

LEDS stock quotes, charts, profile

Growth Rates, Profitability, PE

potato_field_crops_farm_soil_summer_plant_plow-521881 Limoneira Company

Loss on Weak Sales

In the fourth quarter of 2020 earnings season Limoneira Company increased losses of $-0.42 per share compared to $-0.18 a year ago and eps fell from $0.12 per share from the previous quarter.

Sales declined in double digits by -18.38% to $29.77 millions from $36.48 millions in the same quarter a year ago and sequentially Sales Tumbled by -44.41% from $53.56 millions.

LMNR stock quotes, charts, profile

Growth Rates, Profitability, PE

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Cannabics Pharmaceuticals Inc

Deficit Bigger Than a Year Ago but Revenues Unchanged

In the first quarter of 2020 Cannabics Pharmaceuticals Inc loss increased of $-0.01 per share compared to $0.04 a year ago and improved from $-0.08 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

CNBK stock quotes, charts, profile

Growth Rates, Profitability, PE

35058062961_dde46c5567_z Lexaria Bioscience Corp

Lexaria Bioscience Corp announced first quarter of 2020 operating loss of $-0.713121 millions

Lexaria Bioscience Corp announced very strong Sales growth of 379.08% year on year to $0.30 millions in the first quarter of 2020, but increased losses at $-0.24.

compared to previous quarter increased losses from $-0.01 per share and Sales doubled by 122.39 % from $0.13 millions.

LXRP stock quotes, charts, profile

Growth Rates, Profitability, PE



Other CTAS's Earnings Reports

Cintas reported first quarter 2020 earnings

Cintas reported fourth quarter 2020 earnings

Cintas reported third quarter 2020 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CETX's Profile

Stock Price

CETX's Financials

Business Description

Fundamentals

Charts & Quotes

CETX's News

Suppliers

CETX's Competitors

Customers & Markets

Economic Indicators

CETX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071